AIT Therapeutics Inc Stock Nasdaq
Equities
US0014481099
Medical Equipment, Supplies & Distribution
Financials (USD)
Sales 2024 * | 1.44M | Sales 2025 * | 13.2M | Capitalization | 56M |
---|---|---|---|---|---|
Net income 2024 * | -62M | Net income 2025 * | -64M | EV / Sales 2024 * | 30.5 x |
Net cash position 2024 * | 12.15M | Net Debt 2025 * | 2.95M | EV / Sales 2025 * | 4.47 x |
P/E ratio 2024 * |
-0.63
x | P/E ratio 2025 * |
-0.7
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.02% |
Latest transcript on AIT Therapeutics Inc
Managers | Title | Age | Since |
---|---|---|---|
Steven Lisi
CEO | Chief Executive Officer | 53 | 17-01-12 |
Douglas Larson
DFI | Director of Finance/CFO | 53 | 21-08-31 |
Amir Avniel
PSD | President | 50 | 17-01-12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald Bentsur
BRD | Director/Board Member | 58 | 15-07-31 |
William Forbes
BRD | Director/Board Member | 62 | 18-08-12 |
Erick Lucera
BRD | Director/Board Member | 57 | 17-08-09 |
1st Jan change | Capi. | |
---|---|---|
-3.77% | 184B | |
-1.77% | 107B | |
-1.43% | 67.52B | |
+2.06% | 50.06B | |
+9.43% | 45.67B | |
+3.40% | 41B | |
+3.04% | 26.73B | |
+4.64% | 26.47B | |
+15.23% | 25.05B |